Guardian Pharmacy Services, Inc. (GRDN)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $3.13B
Last updated: Nov 17, 2026 at 4:15 PM ET
Guardian Pharmacy Services, Inc. (GRDN) Statistics
Guardian Pharmacy Services (GRDN) has a market cap of $3.13B and an enterprise value of $3.01B. Its trailing P/E is 41.9x.
Total Valuation
Enterprise value is 3.82% below the market cap, as cash exceeds debt.
| Market Cap | $3.13B |
|---|---|
| Enterprise Value | $3.01B |
| Latest price (Nov 17, 2026) | $50.31 |
Key Dates
The next earnings report is expected on Mar 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.2x and 11.9x.
| P/E Ratio | 41.9x |
|---|---|
| Forward P/E | 39.3x |
| P/S Ratio | 2.2x |
| Forward P/S | 2.2x |
| P/B Ratio | 11.9x |
| P/TBV Ratio | 19.4x |
| P/FCF Ratio | 34.9x |
| P/OCF Ratio | 27.5x |
| PEG Ratio | 1.3 |
Enterprise Valuation
Counting debt and cash, the company is valued at 23.7x EBITDA and 33.6x free cash flow.
| EV / Earnings | 39.6x |
|---|---|
| EV / Sales | 2.1x |
| EV / EBITDA | 23.7x |
| EV / EBIT | 28.5x |
| EV / FCF | 33.6x |
Price Statistics
The stock is up 72.24% over 52 weeks and trades 17.55% above its 50-day average.
| Beta (1Y) | 0.65 |
|---|---|
| 52-Week Change | +72.24% |
| 1-Month Change | +25.34% |
| 3-Month Change | +32.50% |
| 6-Month Change | +38.67% |
| Total Return (1Y) | +72.24% |
| Return vs SPY (1Y) | +68.70% |
| Max Drawdown (1Y) | -18.79% |
| Max Drawdown (3Y) | -27.21% |
| Sharpe Ratio (1Y) | 1.40 |
| Correlation with SPY (1Y) | 0.21 |
| 50-Day Average | $42.80 |
| 200-Day Average | $39.04 |
| 52-Week Range | $26.34 to $50.59 |
| RSI (14 Days) | 72.2 |
| Average Volume (20 Days) | 490.91K |
Financial Position
Current assets cover 1.65x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.65x |
|---|---|
| Quick Ratio | 1.33x |
| Debt / Equity | 0.00x |
| Interest Coverage | 163.29x |
Returns and Efficiency
Return on equity is 28.46% over the last 12 months, against a 5-year average of 51.76%.
| Return on Equity (ROE) | 28.46% |
|---|---|
| Return on Assets (ROA) | 15.46% |
| Return on Capital Employed (ROCE) | 33.84% |
| ROE (5Y Average) | 51.76% |
| ROA (5Y Average) | 4.88% |
| Asset Turnover | 3.30x |
| Inventory Turnover | 21.02x |
| Receivables Turnover | 13.78x |
| Cash Conversion Cycle | 6 days |
Taxes
Income tax took 27.68% of pretax income over the last 12 months.
| Income Tax (TTM) | $29.11M |
|---|---|
| Effective Tax Rate | 27.68% |
Scores
GRDN has an Altman Z-Score of 13.31, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 13.31 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.46B over the last 12 months is up 4.85% from the 12 months before.
| Revenue | $1.46B |
|---|---|
| Revenue Growth (YoY) | +4.85% |
| Gross Profit | $327.08M |
| Operating Income | $94.14M |
| Pretax Income | $105.16M |
| Net Income | $76.05M |
| EBITDA | $129.27M |
| EBIT | $105.81M |
| Reported EPS (TTM) | $1.20 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 54.34% of the $491.78M in total assets.
| Cash and Equivalents | $119.66M |
|---|---|
| Total Debt | $0 |
| Net Cash | $119.66M |
| Net Cash Per Share | $1.89 |
| Working Capital | $115.73M |
| Shareholder Equity | $267.24M |
| Book Value Per Share | $4.22 |
| Tangible Book Value | $164.44M |
| Tangible Book Per Share | $2.60 |
| Total Assets | $491.78M |
| Total Liabilities | $212.06M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $22.79M of capital spending, operating cash flow left $91.27M of free cash flow.
| Operating Cash Flow | $114.06M |
|---|---|
| Capital Expenditures | $22.79M |
| Free Cash Flow | $91.27M |
| FCF Per Share | $1.44 |
| Depreciation and Amortization | $23.46M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 6.46%, against a 5-year average of 2.67%.
| Gross Margin | 22.45% |
|---|---|
| Operating Margin | 6.46% |
| Pretax Margin | 7.22% |
| Net Margin | 5.22% |
| EBITDA Margin | 8.87% |
| EBIT Margin | 7.26% |
| FCF Margin | 6.26% |
| Gross Margin (5Y Average) | 20.16% |
| Operating Margin (5Y Average) | 2.67% |
| Net Margin (5Y Average) | 1.43% |
Growth
Revenue grew 16.81% a year over 3 years.
| Revenue Growth (3Y CAGR) | +16.81% |
|---|---|
| Revenue Growth (5Y CAGR) | +14.50% |
| FCF Growth (3Y CAGR) | +28.45% |
| FCF Growth (5Y CAGR) | +8.74% |
| Operating Income Growth (3Y CAGR) | +11.83% |
| Book Value Per Share Growth (2Y CAGR) | +164.12% |
Dividends and Yields
GRDN does not pay a dividend. Its free cash flow yield is 2.86%.
| Earnings Yield | 2.39% |
|---|---|
| FCF Yield | 2.86% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 0.02% |
Peer Position
Against 11 similar companies, GRDN has the 3rd highest P/E.
P/E RatioPeer median 24.6x
P/S RatioPeer median 1.2x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +14.34%
| P/E Ratio | 41.9x vs 24.6x median |
|---|---|
| P/S Ratio | 2.2x vs 1.2x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +4.85% vs +14.34% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GRDN
What is GRDN's market cap?
Guardian Pharmacy Services has a market cap of $3.13B. Its enterprise value, which adds debt and subtracts cash, is $3.01B.
What is GRDN's P/E ratio?
Guardian Pharmacy Services has a trailing P/E ratio of 41.9x and a forward P/E of 39.3x.
How many shares of GRDN are outstanding?
Guardian Pharmacy Services has 63.34M shares outstanding. The count is up 1.96% from a year earlier.
Does GRDN pay a dividend?
No. Guardian Pharmacy Services does not pay a dividend.
How much debt does GRDN have?
Guardian Pharmacy Services has $0 of total debt and $119.66M of cash and equivalents, a net cash position of $119.66M.
GRDN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors